5:00 PM ET
8-K
M&A Deal
Janel Signs $17M M&A Deal with EnCor Biotechnology Inc.
Janel Corporation, through its subsidiary Antibodies Incorporated, acquired 100% of EnCor Biotechnology Inc. for $17 million, consisting of $11.96 million in cash and a $5.04 million subordinated promissory note. The acquisition of the Florida-based biotechnology company was funded through cash on hand and an $11 million draw from an expanded senior credit facility.
- Value
- $17M
- Counterparty
- EnCor Biotechnology Inc.